144 related articles for article (PubMed ID: 34774302)
1. Thrombospondin type-1 domain-containing 7A-related membranous nephropathy associated with glomerular AL amyloidosis.
Morel A; Buob D; Goujon JM; Belhadj K; Verpont MC; Audard V; Moktefi A
Pathology; 2022 Aug; 54(5):654-657. PubMed ID: 34774302
[No Abstract] [Full Text] [Related]
2. Glomerular disease: thrombospondin type-1 domain-containing 7A-a new player in membranous nephropathy.
Allison SJ
Nat Rev Nephrol; 2015 Feb; 11(2):63. PubMed ID: 25447129
[No Abstract] [Full Text] [Related]
3. Clinical significance of M
Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous Remission of Thrombospondin Type-1 Domain-Containing-Associated Membranous Nephropathy.
Watanabe S; Suzuki T; Han W; Nakata M; Koitabashi K; Ichikawa D; Kamijo-Ikemori A; Koike J; Shibagaki Y
Intern Med; 2021 Oct; 60(19):3125-3128. PubMed ID: 33840692
[TBL] [Abstract][Full Text] [Related]
5. Lesson for the clinical nephrologist: thrombospondin type-1 domain-containing protein 7A-associated membranous nephropathy and Fanconi syndrome in a patient with a squamous cell lung cancer.
Zappi S; Bernasconi L; Fischer I; Hoxha E; Wiech T; Minzer A; Irani S; Moosmann P; Kim MJ
J Nephrol; 2023 Nov; 36(8):2395-2399. PubMed ID: 37294401
[No Abstract] [Full Text] [Related]
6. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Gödel M; Grahammer F; Huber TB
N Engl J Med; 2015 Mar; 372(11):1073. PubMed ID: 25760365
[No Abstract] [Full Text] [Related]
7. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Meyer-Schwesinger C; Lambeau G; Stahl RA
N Engl J Med; 2015 Mar; 372(11):1074-5. PubMed ID: 25760364
[No Abstract] [Full Text] [Related]
8. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
9. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
Stahl RA; Reinhard L; Hoxha E
Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
[No Abstract] [Full Text] [Related]
10. Effects of phospholipase A
Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy.
Suzuki T; Han W; Watanabe S; Terashita M; Nakata M; Ichikawa D; Shirai S; Shibagaki Y
Ren Fail; 2020 Nov; 42(1):966-968. PubMed ID: 32935600
[No Abstract] [Full Text] [Related]
12. The latest model has just arrived! A new experimental mouse model of PLA2R1-associated membranous nephropathy.
Beck LH
Kidney Int; 2023 Nov; 104(5):878-880. PubMed ID: 37863634
[TBL] [Abstract][Full Text] [Related]
13. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
14. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
[TBL] [Abstract][Full Text] [Related]
15. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
16. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
[TBL] [Abstract][Full Text] [Related]
17. Prediagnostic Appearance of Thrombospondin Type-1 Domain 7A Autoantibodies in Membranous Nephropathy.
Burbelo PD; Olson SW; Keller JM; Joshi M; Schwartz DM; Chuang YJ; Lambeau G; Beck LH; Waldman M
Kidney360; 2023 Feb; 4(2):217-225. PubMed ID: 36821613
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans.
Lwezaula BF; Ameh OI; Ekrikpo UE; Botha FC; Okpechi-Samuel US; Wearne N; Ronco P; Bello AK; Okpechi IG
BMC Nephrol; 2021 Jan; 22(1):15. PubMed ID: 33413188
[TBL] [Abstract][Full Text] [Related]
19. Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era.
Safar-Boueri L; Piya A; Beck LH; Ayalon R
Pediatr Nephrol; 2021 Jan; 36(1):19-30. PubMed ID: 31811540
[TBL] [Abstract][Full Text] [Related]
20. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.
Shirai S; Akiyama S; Kamijo-Ikemori A; Suzuki T; Ichikawa D; Koike J; Kimura K; Shibagaki Y
CEN Case Rep; 2020 Feb; 9(1):65-73. PubMed ID: 31705303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]